CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

131 hedge funds and large institutions have $1.17B invested in Celldex Therapeutics in 2021 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 33 increasing their positions, 36 reducing their positions, and 24 closing their positions.

Holders
131
Holders Change
+16
Holders Change %
+13.91%
% of All Funds
2.29%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
40
Increased
33
Reduced
36
Closed
24
Calls
$33.4M
Puts
$39.5M
Net Calls
-$6.09M
Net Calls Change
-$12.3M

Top Buyers

1
BlackRock
1
BlackRock
New York
$90.3M
2
PA
2
Perceptive Advisors
New York
$24.8M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$22.5M
4
Northern Trust
4
Northern Trust
Illinois
$13.8M
5
DCM
5
Driehaus Capital Management
Illinois
$19.6M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$12.4M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$3.56M
3
RG
3
Redmile Group
California
$101M
4
VC
4
Vivo Capital
California
$32.4M
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JCM
151
Jacobi Capital Management
Pennsylvania
– -$8K -400 Closed
MLFP
152
MPS Loria Financial Planners
Illinois
– -$2K -133 Closed
Bank of Montreal
153
Bank of Montreal
Ontario, Canada
– -$1K -60 Closed
3 4 5 6
7